Koyfin Home > Directory > Health Care > Adamas Pharma > Enterprise Value

Adamas Pharma Enterprise Value Chart (ADMS)

Adamas Pharma annual/quarterly Enterprise Value from 2014 to 2020.
  • Adamas Pharma Enterprise Value for the quarter ending September 09, 2020 was $168m a -0.17% decrease of 0m year over year
  • Adamas Pharma Enterprise Value for the last 12 months ending September 09, 2020 was $168m a -0.17% decrease of 0m year over year
  • Adamas Pharma Annual Enterprise Value for 2020 was $168m a -0.17% decrease of 0m from 2019
  • Adamas Pharma Annual Enterprise Value for 2020 was $168m a 0.50% increase of 1m from 2019
  • Adamas Pharma Annual Enterprise Value for 2020 was $167m a -0.51% decrease of -1m from 2019
Other Valuation Metrics:
  • Adamas Pharma Market Cap for the quarter ending March 03, 2018 was $641m a 38.96% increase of 250m year over year
  • Adamas Pharma Price / Book for the quarter ending March 03, 2018 was 8.43 a 61.32% increase of 5.17 year over year
View Chart On Koyfin

Quarterly ADMS Enterprise Value Data

09/2020$168m
09/2020$168m
09/2020$167m
09/2020$168m
09/2020$164m
09/2020$159m
09/2020$155m
09/2020$156m
09/2020$155m
09/2020$177m

Annual ADMS Enterprise Value Data

2020$168m
2020$168m
2020$167m
2020$168m
2020$164m
2020$159m
2020$155m
2020$156m
2020$155m
2020$177m